# Harungana (Harungana madagascariensis)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/harungana-harungana-madagascariensis
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** Middle Eastern
**Also Known As:** Harongana, Dragon's blood tree (African), Haronga, Harungana madagascariensis (Harungana madagascariensis Lam. ex Poir.), Orange-milk tree, Harungana madagascariensis Lam. ex Poir., Harungana madagascensis (Harungana madagascariensis)

## Overview

Harungana madagascariensis contains flavonoids, phenolics, anthraquinones, alkaloids, and tannins that disrupt microbial membrane integrity and inhibit catalase activity in pathogens such as Pseudomonas aeruginosa, while exerting antioxidant activity through [free radical scaveng](/ingredients/condition/antioxidant)ing. Leaf extracts demonstrate potent antibacterial synergy, reducing the minimum inhibitory concentration of doxycycline by at least 16-fold at sub-inhibitory concentrations (MIC/8) in vitro, supporting its traditional role in managing infections, hemorrhoids, and trypanosomiasis.

## Health Benefits

- **[Antimicrobial](/ingredients/condition/immune-support) Activity**: Leaf and bark extracts demonstrate antibacterial efficacy against a range of pathogens, with MIC values spanning 16–2048 μg/mL in vitro; flavonoids and phenolics disrupt cytoplasmic membrane integrity to inhibit bacterial growth.
- **Antibiotic Potentiation**: At sub-inhibitory concentrations (MIC/8), harungana leaf extract reduces the MIC of doxycycline by ≥16-fold against Pseudomonas aeruginosa by inhibiting bacterial catalase and compromising membrane function, suggesting utility as an antibiotic adjunct.
- **[Antioxidant Protection](/ingredients/condition/antioxidant)**: Leaf extracts contain exceptionally high phenolic content (107.41 ± 9.66 mg GAE/g extract) and flavonoids (53.67 ± 5.09 mg QE/g extract), conferring potent free radical scavenging capacity that may protect tissues from oxidative damage.
- **Antiprotozoal and Antitrypanosomal Effects**: Traditional North African and Malagasy use for trypanosomiasis is corroborated by in vitro antiprotozoal activity attributed to alkaloids and anthraquinones, though clinical confirmation is absent.
- **Antisickling Properties**: Extracts have been screened for antisickling activity relevant to sickle cell disease management in endemic African regions, with phytochemical fractions implicated in altering red blood cell morphology under deoxygenating conditions.
- **[Anti-inflammatory](/ingredients/condition/inflammation) and Hemorrhoid Relief**: Stem bark preparations are traditionally applied for piles (hemorrhoids), with tannins and flavonoids providing astringent and anti-inflammatory effects that reduce vascular permeability and tissue inflammation.
- **Antiproliferative Potential**: Preliminary in vitro data indicate cytotoxic or antiproliferative activity against certain cell lines, attributed to anthraquinone and alkaloid fractions, though mechanistic and dose–response data remain incompletely characterized.

## Mechanism of Action

Flavonoids and phenolics in harungana leaf extracts disrupt the structural integrity of bacterial cytoplasmic membranes, causing leakage of intracellular contents and potentiating the activity of conventional antibiotics such as doxycycline. Concurrently, these extracts inhibit bacterial catalase activity in Pseudomonas aeruginosa, impairing the pathogen's defense against [reactive oxygen species](/ingredients/condition/antioxidant) and amplifying oxidative stress-mediated killing. Anthraquinone derivatives and alkaloids are thought to intercalate with nucleic acids or interfere with topoisomerase function, contributing to antiprotozoal and antiproliferative effects, though specific receptor-level interactions have not been quantified in available literature. Tannins contribute astringent and protein-precipitating actions relevant to wound healing and hemorrhoid management, while free radical scavenging by polyphenols reduces lipid peroxidation and oxidative tissue injury through hydrogen atom transfer and electron donation mechanisms.

## Clinical Summary

No human clinical trials investigating Harungana madagascariensis have been identified in the peer-reviewed literature. Available pharmacological data are restricted to in vitro antibacterial, antiprotozoal, antisickling, and antiproliferative screening assays without defined sample sizes, patient populations, or clinical endpoints. While traditional use across Africa and Madagascar provides centuries of observational support for applications including hemorrhoid treatment and management of trypanosomiasis, this evidence cannot substitute for controlled human studies. Confidence in clinical efficacy remains very low, and all purported benefits require validation through properly designed preclinical animal studies and, subsequently, Phase I/II human trials before therapeutic recommendations can be made.

## Nutritional Profile

Harungana madagascariensis stem bark methanolic extract contains modest quantities of minerals and vitamins per 100 g dry weight, including iron (2.50 ± 0.02 mg), magnesium (25.99 ± 0.04 mg), vitamin B1/thiamine (23.14 ± 0.03 mg), vitamin B2/riboflavin (18.22 ± 0.03 mg), and vitamin C/ascorbic acid (0.26 ± 0.01 mg). Antinutrient levels are reassuringly low: phytic acid (0.01 ± 0.01 mg/100 g), soluble oxalate (3.03 ± 0.02 mg/100 g, below the 2–5 g/100 g toxic threshold in concentrated form), and hydrogen cyanide (0.75 mg/100 g, well below the lethal threshold of 35 mg/100 g). Leaf extracts are phytochemically dense, with phenolics at 107.41 ± 9.66 mg GAE/g extract and flavonoids at 53.67 ± 5.09 mg QE/g extract, alongside qualitatively high (+++) levels of alkaloids, saponins, and glycosides. Bioavailability of these constituents in humans is entirely unstudied; the presence of tannins and saponins may reduce absorption of co-administered minerals and proteins through chelation and membrane interactions.

## Dosage & Preparation

- **Traditional Decoction (Stem Bark)**: Bark is boiled in water and the decoction taken orally for gastrointestinal complaints, piles, and infectious conditions; no standardized dose is established.
- **Leaf Infusion**: Fresh or dried leaves are steeped in hot water and consumed as a tea; qualitative phytochemical content is highest when leaves are freshly processed.
- **Methanolic Extract (Research Use)**: Laboratory preparations use methanol as solvent yielding alkaloids (1.14 ± 0.08 mg/100 g DW), tannins (0.97 ± 0.02 mg/100 g DW), and saponins (0.48 ± 0.09 mg/100 g DW); no human dose equivalent has been derived.
- **Dichloromethane Extract (Research Use)**: Produces distinct phytochemical fractions (saponins 0.37 ± 0.07 mg/100 g DW; alkaloids absent) used in [antimicrobial](/ingredients/condition/immune-support) screening only.
- **Optimal Harvest Timing**: Traditional knowledge suggests stem bark harvested at approximately 6 pm yields the highest antibacterial activity in aqueous and organic extracts.
- **No Commercial Supplement Form**: No standardized capsule, tablet, or tincture formulation exists; effective supplemental doses, standardization percentages, and pharmacokinetic parameters are entirely undefined.

## Safety & Drug Interactions

In vitro and phytochemical analyses indicate that antinutrient and cyanogenic glycoside levels in harungana bark extracts fall below established toxic thresholds, suggesting low acute toxicity at traditionally used quantities; however, no formal toxicological studies, LD50 determinations, or repeated-dose safety assessments in animals or humans have been published. The presence of cardiac glycosides detected qualitatively in leaf and bark fractions warrants caution in individuals with cardiac arrhythmias, heart failure, or those taking digoxin or other cardiac glycoside-based medications, as additive cardiotoxic effects are plausible. No documented drug interactions, contraindications, or adverse effect profiles exist in the peer-reviewed literature, meaning safety cannot be affirmed or denied for concurrent use with anticoagulants, antidiabetics, hepatotoxic agents, or immunosuppressants. Use during pregnancy and lactation is not supported by any safety data and should be avoided until evidence is available; maximum safe doses remain undefined for any route of administration or population group.

## Scientific Research

All published evidence for Harungana madagascariensis derives exclusively from in vitro and phytochemical screening studies; no human clinical trials or animal pharmacokinetic studies have been published in the indexed literature as of the available research context. Antibacterial activity has been quantified with MIC values ranging from 16 to 2048 μg/mL across different bacterial species and solvent extracts, and synergistic antibiotic potentiation with doxycycline (≥16-fold MIC reduction) has been demonstrated in cell-free and bacterial culture systems. Phytochemical profiling studies have documented high phenolic (107.41 ± 9.66 mg GAE/g) and flavonoid (53.67 ± 5.09 mg QE/g) concentrations in leaf extracts and low antinutrient levels in stem bark methanolic extracts, but these lack standardization to a single reference compound or authenticated commercial extract. The overall evidence base is preclinical and fragmented, with no dose–response data in mammals, no bioavailability assessments, and no controlled efficacy endpoints, placing this ingredient firmly in the preliminary evidence category.

## Historical & Cultural Context

Harungana madagascariensis has been used in traditional African and Malagasy medicine for centuries, with documented applications spanning hemorrhoid treatment, management of skin infections, malaria, trypanosomiasis, and sickle cell disease across Central, West, and East African communities as well as Madagascar. In North African traditional pharmacopeia, the plant is among remedies cited for parasitic infections including trypanosomiasis, reflecting knowledge transmission along trans-Saharan trade and migration routes. Preparation methods vary by region, with healers in some communities favoring bark decoctions for internal use and leaf poultices for topical wound and skin conditions, while in Madagascar macerated plant material is applied in ritual and medicinal contexts. The plant's bright red-orange latex exuded from cut bark is a recognizable feature that traditional practitioners associate with its potent medicinal properties, and in several West African systems the latex itself is applied topically to ulcers and fungal skin lesions.

## Synergistic Combinations

Harungana leaf extracts demonstrate documented synergy with doxycycline, reducing its minimum inhibitory concentration against Pseudomonas aeruginosa by at least 16-fold through complementary mechanisms of membrane disruption and catalase inhibition, suggesting potential utility as an antibiotic-adjunctive botanical when conventional antibiotic resistance is a concern. Phenolic-rich plant combinations commonly used in African traditional polyherbal formulations, such as pairing harungana with other antioxidant-rich barks (e.g., Garcinia kola or Combretum species), may enhance cumulative [free radical scaveng](/ingredients/condition/antioxidant)ing capacity through additive polyphenol contributions, though this has not been formally tested. Co-administration with iron-rich foods or supplements warrants caution, as tannin and oxalate content, although low, could theoretically reduce non-heme iron bioavailability through chelation.

## Frequently Asked Questions

### What is Harungana madagascariensis used for traditionally?

Traditionally, Harungana madagascariensis is used across sub-Saharan Africa and Madagascar for treating hemorrhoids (piles), trypanosomiasis, skin infections, malaria, and sickle cell disease. Stem bark decoctions are taken orally for internal complaints, while fresh latex and leaf poultices are applied topically to wounds, ulcers, and fungal skin conditions. These uses are supported by in vitro antimicrobial and antiprotozoal activity but have not been validated in human clinical trials.

### Does Harungana madagascariensis have proven antibacterial effects?

In vitro studies show that harungana leaf and bark extracts inhibit bacterial growth with minimum inhibitory concentration (MIC) values ranging from 16 to 2048 μg/mL, and leaf extracts reduce the MIC of doxycycline against Pseudomonas aeruginosa by at least 16-fold at sub-inhibitory concentrations. This antibiotic-potentiating effect is attributed to membrane disruption and catalase inhibition caused by flavonoids and phenolics. However, all evidence is from laboratory cell culture experiments; no human clinical trials have confirmed these antibacterial effects in patients.

### What are the main bioactive compounds in Harungana madagascariensis?

The primary bioactive compounds include flavonoids (53.67 ± 5.09 mg QE/g in leaf extracts), phenolics (107.41 ± 9.66 mg GAE/g in leaf extracts), alkaloids (1.14 ± 0.08 mg/100 g DW in methanolic bark extract), tannins (0.97 ± 0.02 mg/100 g DW), saponins, anthraquinones, and cardiac glycosides. Anthraquinones and alkaloids are associated with antiprotozoal and antiproliferative activity, while tannins contribute astringent effects relevant to hemorrhoid management. The dichloromethane bark extract notably lacks detectable alkaloids but retains saponin content.

### Is Harungana madagascariensis safe to use?

Phytochemical analyses show that cyanogenic glycoside (HCN: 0.75 mg/100 g) and oxalate levels (3.03 mg/100 g) in harungana bark extracts fall below established toxic thresholds, suggesting low acute toxicity in typical traditional preparation amounts. However, the qualitative presence of cardiac glycosides raises concern for individuals with heart conditions or those taking cardiac medications such as digoxin. No formal human toxicology studies, defined maximum safe doses, or pregnancy safety data exist, so use by pregnant or lactating individuals and those on cardiac medications should be avoided until more data are available.

### What is the recommended dose of Harungana madagascariensis supplement?

No standardized supplemental dose for Harungana madagascariensis has been established through clinical research, and no commercial standardized extract, capsule, or tablet formulation is currently available. All dosing information derives from traditional practices using bark decoctions or leaf infusions prepared at home without defined quantities or active compound concentrations. Until pharmacokinetic studies and human clinical trials define safe and effective doses, specific dosage recommendations cannot be made.

### Can Harungana madagascariensis enhance the effectiveness of antibiotics?

Yes, research indicates that Harungana leaf extract can potentiate antibiotic activity, reducing the minimum inhibitory concentration (MIC) of doxycycline by 16-fold or greater at sub-inhibitory doses. This synergistic effect suggests harungana may help restore antibiotic efficacy against resistant bacterial strains. However, this combination should only be used under medical supervision to avoid adverse interactions.

### How do the antimicrobial compounds in Harungana madagascariensis work against bacteria?

The flavonoids and phenolic compounds in harungana leaf and bark extracts disrupt the cytoplasmic membrane integrity of bacterial cells, inhibiting their growth and reproduction. In vitro studies show antimicrobial activity with minimum inhibitory concentrations ranging from 16–2048 μg/mL depending on the pathogen tested. This mechanism of action is distinct from many conventional antibiotics, making it potentially useful for multi-resistant organisms.

### Is Harungana madagascariensis more effective as a leaf extract or bark extract?

Both leaf and bark extracts of Harungana madagascariensis demonstrate antimicrobial activity with comparable efficacy profiles in vitro. The choice between them may depend on bioavailability, preparation method, and the specific health condition being addressed, though direct comparative clinical studies are limited. Traditional use favors the leaf extract, suggesting practical or cultural preferences may guide selection.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*